Dapagliflozin add-on to metformin therapy in diabetic patients
Not Applicable
- Conditions
- Health Condition 1: E11- Type 2 diabetes mellitus
- Registration Number
- CTRI/2022/12/048622
- Lead Sponsor
- Aditya kumar
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Patients with T2DM inadequately controlled with Metformin 1-2 gm per day
2. Those patients who are unable to tolerate further increase in further dose of Metformin
3. Patients aged 30 to 70 years
4. HbA1C 7.0% to 9.0%
Exclusion Criteria
1. Patient who are on insulin
2. Patient described any other anti diabetic medication after adding Dapagliflozin to Metformin
3. Patients in which dose of metformin has to be altered
4. Patients with renal insufficiency (GFR lress than 30ml/min/1.73m2)
5. Patients who are known case of urinary tract infection , structural abnormalities of urinary tract.
6. Patients with acute complications of diabetes mellitus
7. Patients with hypersensitivity to drug
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method